Grant & Eisenhofer Files Securities Class Action Lawsuit Against Canadian Imperial Bank of Commerce and Royal Bank of Canada on behalf of investors in Quantum Biopharma Ltd. Securities
I'm PortAI, I can summarize articles.
Grant & Eisenhofer has filed a class action lawsuit against the Canadian Imperial Bank of Commerce and Royal Bank of Canada on behalf of Quantum Biopharma Ltd. investors. The lawsuit alleges that the banks engaged in manipulative trading practices to deflate Quantum's stock price. The case, filed in the Southern District of New York, seeks to represent investors who sold Quantum securities between January 6, 2021, and October 15, 2025. Potential lead plaintiffs must move the court by February 23, 2026.
Source: MorningStar The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments